Temoporfin

Jump to: navigation, search
Temoporfin
Temoporfin.png
Clinical data
AHFS/Drugs.comInternational Drug Names
[[Regulation of therapeutic goods |Template:Engvar data]]
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC44H32N4O4
Molar mass680.74 g/mol
3D model (JSmol)
  (verify)

WikiDoc Resources for Temoporfin

Articles

Most recent articles on Temoporfin

Most cited articles on Temoporfin

Review articles on Temoporfin

Articles on Temoporfin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Temoporfin

Images of Temoporfin

Photos of Temoporfin

Podcasts & MP3s on Temoporfin

Videos on Temoporfin

Evidence Based Medicine

Cochrane Collaboration on Temoporfin

Bandolier on Temoporfin

TRIP on Temoporfin

Clinical Trials

Ongoing Trials on Temoporfin at Clinical Trials.gov

Trial results on Temoporfin

Clinical Trials on Temoporfin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Temoporfin

NICE Guidance on Temoporfin

NHS PRODIGY Guidance

FDA on Temoporfin

CDC on Temoporfin

Books

Books on Temoporfin

News

Temoporfin in the news

Be alerted to news on Temoporfin

News trends on Temoporfin

Commentary

Blogs on Temoporfin

Definitions

Definitions of Temoporfin

Patient Resources / Community

Patient resources on Temoporfin

Discussion groups on Temoporfin

Patient Handouts on Temoporfin

Directions to Hospitals Treating Temoporfin

Risk calculators and risk factors for Temoporfin

Healthcare Provider Resources

Symptoms of Temoporfin

Causes & Risk Factors for Temoporfin

Diagnostic studies for Temoporfin

Treatment of Temoporfin

Continuing Medical Education (CME)

CME Programs on Temoporfin

International

Temoporfin en Espanol

Temoporfin en Francais

Business

Temoporfin in the Marketplace

Patents on Temoporfin

Experimental / Informatics

List of terms related to Temoporfin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Temoporfin (INN) is a photosensitizer (based on chlorin) used in photodynamic therapy for the treatment of squamous cell carcinoma of the head and neck[1] .[2] It is marketed in the European Union under the brand name Foscan. The U.S. Food and Drug Administration (FDA) declined to approve Foscan in 2000. The EU approved its use in June 2001.[3]

Good results were obtained in 21 of 35 patients treated in Germany.[4]

It is photoactivated at 652 nm[5] i.e. by red light.

Patients can remain photosensitive for several weeks after treatment.[2]

Further reading

References

  1. Lorenz KJ, Maier H (April 2008). "[Squamous cell carcinoma of the head and neck. Photodynamic therapy with Foscan]". HNO (in German). 56 (4): 402–9. doi:10.1007/s00106-007-1573-1. PMID 17516041.
  2. 2.0 2.1 O'Connor, Aisling E, Gallagher, William M, Byrne, Annette T (2009). "Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy. Photochemistry and Photobiology, Sep/Oct 2009". Photochemistry and Photobiology.
  3. http://www.highbeam.com/doc/1P2-18794532.html Foscan approval saves Scotia's skin.
  4. http://www.springerlink.com/content/g74w224824v8l013/
  5. "Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy". Photochemistry and Photobiology. 2009.

Linked-in.jpg